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Summary
Objective: To investigate the role of sex hormones in cartilage degradation and progression of osteoarthritis (OA) in a murine model induced
by destabilization of the medial meniscus (DMM).
Design: Accelerated OA development in mice was induced by transection of the menisco-tibial ligament, which anchors the medial meniscus
to the tibial plateau. Intact male and female, and orchiectomized (ORX) male and ovariectomized (OVX) female mouse knee histology were
compared for signs of OA following DMM. The effect of testosterone or estrogen addition in vivo was assessed in ORX males in the surgical
OA model.
Results: OA severity was markedly higher in males than females after DMM. OVX females developed signiﬁcantly more severe OA than con-
trol females. ORX males developed signiﬁcantly less severe OA than control males. When ORX male mice were supplemented with exoge-
nous dihydrotestosterone (DHT), the severity of OA was restored to the level experienced by the control male mice. Hip cartilage from mice of
both sexes demonstrated similar spontaneous and interleukin-1a (IL-1a) induced proteoglycan (PG) release in vitro. DHT and 17-b estradiol
(E2) did not signiﬁcantly alter the PG release pattern when supplemented to cartilage cultures of either sex.
Conclusion: Sex hormones play a critical role in the progression of OA in the murine DMM surgical model, with males having more severe OA
than females. Intact females had more OA than OVX females, indicating that ovarian hormones decrease the severity of OA in the female
mice. Male hormones, such as testosterone, exacerbate OA in male mice as demonstrated by the fact that ORX mice experienced less
OA than intact males, and that addition of DHT to ORX males was able to counteract the effect of castration and re-establish severe OA.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is a slowly progressive, chronic joint dis-
ease characterized by cartilage matrix breakdown that may
ultimately lead to complete loss of articular cartilage.Genetic,
hormonal, metabolic, environmental and biomechanical
mechanisms all contribute to the pathogenesis of OA1.
Epidemiological studies have shown that there are signif-
icant sex differences in both the prevalence and the clinical
manifestations of OA2,3. OA is more prevalent in men than
women before age 50. After menopause, the incidence of
OA in women increases. Postmenopausal women have
OA that affects multiple joints with greater severity, suggest-
ing a chondro-protective effect of female hormones4e6. In
different strains of mice which develop spontaneous OA, it
has long been documented that male mice had a higher in-
cidence of degenerative joint disease than females7e9. In
the collagenase induced OA model10, male mice also de-
velop more OA than females. In the surgical destabilization
of the medial meniscus model (DMM)11,12, we have ob-
served that female mice of 129SvEv, FVB/N and C57BL/6
strains develop less OA than males (unpublished
observations).
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present in both male and female chondrocytes13e17 and
yet the effect of sex hormones on chondrocyte activity
seems to be sex-speciﬁc18e21. The exact role of male and
female hormones in OA pathogenesis is not well under-
stood but it is tempting to speculate that sex hormones
may directly or indirectly inﬂuence the progression of OA.
In this study, the contribution of sex hormones on cartilage
degradation was evaluated in vivo via a surgically induced
joint instability model of OA.
Materials and methods
MICE
Three to nine week old intact and orchiectomized (ORX)
129S6/SvEv male mice, and intact and ovariectomized
(OVX) 129S6/SvEv female mice were purchased from Ta-
conic (Germantown, NY). All mice were housed in group
sizes of ﬁve per cage and treated in accordancewith National
Institutes of Health and American Association of Laboratory
Animal Care regulations, in an Institutional Animal Care and
Use Committee approved protocol.
HIP CARTILAGE ISOLATION AND CULTURE OF CARTILAGE
EXPLANTS
Femoral head cartilage of intact 3e4 week old 129S6/
SvEv male and female mice was harvested as previously5
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heads was placed in each well of a 96-well plate, and cul-
tured in triplicate. The cartilage was rested in DMEM media
(with 10% fetal bovine serum) for 2 days and then cultured
in serum-free Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM) plus 5 ng/ml of mouse IL-1a (Sigma, St Louis,
MO). Conditioned media was collected 48 h later and carti-
lage harvested at the end of the culture period. To deter-
mine the effect of sex hormones on IL-1a induced
proteoglycan (PG) release from cartilage, various con-
centrations of E2 or dihydrotestosterone (DHT; Sigma,
St Louis, MO) were supplemented to the culture at the
time of IL-1a addition.
QUANTITATION OF PG
PG content in the media and digested cartilage were
measured as sulfated glycosaminoglycan (GAG) using the
dimethylmethylene blue (DMMB) assay with whale chon-
droitin sulfate as a standard (Sigma, St Louis, MO)23.
GAG content in the remaining cartilage was measured fol-
lowing overnight digestion with proteinase K at 56C. The
percentage GAG release from the ex vivo studies was ob-
tained by dividing the GAG content in the conditioned media
by the combined GAG in the media and cartilage.
SURGICAL INDUCTION OF OA BY DMM
Knee joint instability was induced surgically in age
matched 129S6/SvEv mice. Male and female castrated
Fig. 1. 129S6/SvEv male mice developed more severe OA than fe-
males. Age matched male and female 129/SvEv mice were sacri-
ﬁced at 2, 4 and 8 weeks after surgical induction of joint instability.
Histologic sections through the joints were stained and scored for
cartilage damage (**P< 0.01).mice were obtained from Taconic that had undergone orchi-
ectomy or ovariectomy at 6 weeks of age. In the case of hor-
mone treatment, male castrated mice were implanted
subcutaneously with pellets (Innovative Research of Amer-
ica, Sarasota, FL) containing either placebo, DHT (12.5 mg/
60 day release pellet) or E2 (0.72 mg/60 day release pallet)
at the time of instability surgery according to manufacturer’s
suggestion. These doses correspond to physiological levels
of DHT (4e6 ng/ml) and E2 (500e600 pg/ml) in male and fe-
male mice, respectively24,25.
At 10 weeks of age, mice were anesthetized with intra-
peritoneal tribromoethanol (Aldrich, Milwaukee, WI) and
DMM induced by transection of the anterior attachment of
the medial meniscus to the tibial plateau. All mice were
weight bearing following recovery from anesthesia. A sub-
set of mice was sacriﬁced at 2, 4 or 8 weeks post-opera-
tively for initial characterization of the model.
Subsequently, all animals were sacriﬁced at 8 weeks post
surgery. Coronal (frontal) histologic sections were taken
through the joint at 70 mm intervals, stained with Safranin-
O and scored by two to three blinded observers using
a modiﬁcation of a published mouse scoring system by
Chambers et al.26. A score of 0 represents normal cartilage;
0.5¼ loss of Safranin-O without structural changes;
1¼ roughened articular surface and small ﬁbrillations;
2¼ ﬁbrillation down to the layer immediately below the su-
perﬁcial layer and some loss of surface lamina; and 3¼mild
(<20%), 5¼moderate (20%e80%) and 6¼ severe (>80%)
loss of articular cartilage11,12. Histological scores were ap-
plied to all four quadrants (medial tibial plateau, medial fem-
oral condyle, lateral tibial plateau, lateral femoral condyle) of
the right knee joints at all levels to obtain summed scores.
Average group sizes of 10 (range 6e11) were used in
each DMM cohort, with 139 mice in total. Statistical analy-
ses for nonparametric data utilized a ManneWhitney
U test for the histologic data and a KruskaleWallis with
Dunn’s post-test for the weight data (GraphPad Prism,
San Diego, CA).
Results
OA SEVERITY AFTER SURGICAL INDUCTION OF JOINT
INSTABILITY IN MALE AND FEMALE MICE
Histologic mouse knee sections were scored for damage
at various time points after surgery. OA was more severe in
129S6/SvEv male mice than females following DMM at all
time points evaluated (Fig. 1). The difference between
males and females became signiﬁcant (P< 0.001) at 4
and 8 weeks post surgery. At 8 weeks, extensive ﬁbrillation,Fig. 2. Safranin-O-staining showing severe loss of PG, ﬁbrillation and erosion of the medial femoral condyle and tibia plateau cartilage in male
mice (A). Safranin-O-staining showing slight PG loss to the medial tibial plateau of female mice at 8 weeks post-operatively (B). T¼ tibia;
F¼ femur; Arrow depicts most severe lesion. 10 magniﬁcation.
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served in males [Fig. 2(A)], while superﬁcial ﬁbrillation or lo-
calized PG loss was a feature in the females [Fig. 2(B)]. In
contrast, un-operated knees from both male and female
mice showed little or no histopathologic evidence of OA at
these time points (data not shown). The summed mean
score of male mice (35.8 7.2) was more than four-fold
higher than that of female mice (8.5 1.1) at 8 weeks after
surgery.
EFFECT OF HORMONE SUPPLEMENTATION ON EX VIVO PG
RELEASE
Femoral head cartilage of 3e4 week old male and female
mice was harvested as described previously22 and cultured
in DMEM conditioned media with or without IL-1a. Analysis
of GAG content of the media revealed similar spontaneous
and IL-1a induced GAG release by articular cartilage from
male and female mice (Fig. 3).
To evaluate the effects of E2 and DHT on cytokine-chal-
lenged GAG release from mouse cartilage of different
sexes, these sex hormones were supplemented at 0.01,
0.1, 1, 10 and 100 nM to the ex vivo explant cultures in
the presence of IL-1a. Neither E2 nor DHT supplementation
to male or female cartilage impacted the IL1-a induced
GAG release in this ex vivo system (results not shown).
SEX HORMONES MODULATE OA SEVERITY IN MALE
AND FEMALE MICE
Histologic sections from the knee joints of control and
OVX females as well as control and ORX male mice were
scored and expressed as a summed score of all the sec-
tions. The OVX mice had signiﬁcantly more severe OA le-
sions (44% higher scores, P< 0.05) than the control
females, albeit still less severe than the control male mice
[Fig. 4]. The age matched OVX mice weighed 8% and
11% more than the control females at the beginning and
at the end of study, respectively (Table I), but were not sig-
niﬁcantly different. The weights of the intact males were sig-
niﬁcantly greater than intact and OVX females, at surgery
and at sacriﬁce. At sacriﬁce, the ORX males also weighed
signiﬁcantly more than intact and OVX females.
The role of male sex hormones was investigated by com-
paring the OA progression in control and ORX male mice.
ORX males had 47% lower OA scores than the control
male mice [Fig. 4]. ORX males weighed less than the
Fig. 3. Cartilage from male and female mice experienced similar
spontaneous and IL-1a induced GAG release in explant culture.
Hip cartilage from 129/SvEv male and female mice was harvested
and cultured in the presence or absence of IL-1a for 2 days. Percent-
age total GAG release was determined using the DMMB assay.control males at the beginning (9% less) and at the end
(5% less) of the study (Table II). Despite the modest, non-
signiﬁcant body weight differences between control and
ORX mice, castration dramatically reduced the OA severity
in male mice by 47%, suggesting that male hormones may
accentuate OA in this model [Fig. 4].
DHT RESTORED OA SEVERITY IN ORX MICE
Due to the dramatic differences in OA severity between
ORX and control male mice, the effect of exogenous sex
hormones was further evaluated in ORX mice by implanting
either placebo, DHT or E2 pellets subcutaneously. OA se-
verity scores (Fig. 5) revealed that ORX alone had signiﬁ-
cantly (P< 0.001) reduced the severity of OA in castrated
placebo mice by 50%, which is comparable to our previous
observations in non-implanted mice. Compared to placebo
treatment, E2 supplemented during the study did not signif-
icantly alter the progression of OA in ORX mice. However,
DHT treatment completely restored the OA severity of ORX
mice to that of control males, and the DHT treated ORX
mice had signiﬁcantly more OA (P< 0.001) than the pla-
cebo treated ORX mice. As depicted by the histologic sec-
tions in Fig. 6, more severe cartilage damage was observed
in intact males and DHT treated ORX mice [Fig. 6(A,D)]
than the placebo and E2 treated ORX mice [Fig. 6(B,C)].
This underscored the importance of testosterone in OA sus-
ceptibility in male mice. Moreover, the effect of DHT on OA
was independent of body weight, as the testosterone-
treated group had comparable body weights to the placebo
control (ORX) mice (Table II).
Fig. 4. OVX mice developed more severe OA than control females.
Age and strain matched control male and female or castrated mice
were sacriﬁced at 8 weeks after surgical induction of joint instability.
Histologic sections were scored for cartilage damage (*P< 0.05
and **P< 0.01 against male controls; #P< 0.05 against female
controls).
Table I
Weight change in mice with ovariectomy or orchiectomy before and
after knee joint instability surgery. Values are means standard de-
viation (SD). Differences between treated mice and intact were as-
sessed using a KruskaleWallis with Dunn’s post-test
Sex Treatment n Body weight (g)
At surgery At sacriﬁce
Female None 10 20.1 1.62 18.7 1.14
Female OVX 10 21.7 0.96 20.7 1.63
Male None 10 25.4 1.76*## 27.7 2.65*#
Male ORX 10 23.1 + 1.55 26.2 + 1.84*#
*P< 0.001 vs control female, #P< 0.05 vs ORX and
##P< 0.001 vs ORX.
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Murine OA models can further elucidate the pathophysiol-
ogy of OA. A number of biochemical features observed in
murine OA models, such as matrix PG depletion by extra-
cellular proteinases, are similar to changes found in human
OA cartilage11,12,26e30. Using a surgical knee instability
model we report that progression of murine OA is sex de-
pendent. In vivo, ovarian-derived hormones have chon-
dro-protective effects on OA in females, whereas
testosterone has a detrimental effect on the severity of
OA in males.
Differences in OA severity between male and female mice
after DMM became apparent as early as 2 weeks after sur-
gery with more extensive cartilage damage observed in
male mice with time progression. The protection observed
in female mice was dramatic and similar in magnitude to the
protection observed in mice deﬁcient in A Disintegrin and
Metalloprotease with Thrombospondin-like repeats-511.
Using this model, we also observed lower amounts of OA in
female FVB/N and C57BL/6 mice (when compared to male
controls), suggesting that the development of more severe
OA in male mice is not a phenomenon restricted to the
129S6/SvEv strain. Female mice are reported to develop
less OA in the intra-articular collagenase injection model as
well as spontaneous OA models10,31,32. These results indi-
cate that the occurrence of more severe OA in males is not
isolated to a particular strain or model system.
Aggrecan is one of the major components of cartilage
and its degradation is indicative of cartilage extracellular
Table II
Weight change in male mice with orchiectomy and hormone treat-
ment before and after knee joint instability surgery. Values are
meansSD. Differences between mice, at the surgery or sacrifice
time point, were assessed using a KruskaleWallis with Dunn’s post
test
Sex Treatment n Body weight (g)
At surgery At sacriﬁce
Male None 10 24.2 1.76 28.8 1.51
ORX Placebo 10 23.1 1.55 26.3 1.85
ORX E2 10 22.1 1.41* 24.2 2.14**
ORX DHT 9 22.6 1.269 26.3 2.59
*P< 0.05 and **P< 0.001 vs control male.
Fig. 5. DHT is responsible for more severe OA in surgically induced
murine OA model. ORX mice treated with placebo, E2, or DHT,
along with control male mice underwent knee destabilization sur-
gery. Eight weeks later, mice were sacriﬁced and knee histologic
sections were scored. *P< 0.05 and **P< 0.01 against male con-
trols; ##P< 0.01 against ORX +DHT.matrix destruction. To assess whether the difference in
OA severity observed between male and females is due
to differences in their spontaneous and cytokine-challenged
cartilage degradation, PG release from cartilage of male
and female mice was analyzed. We observed comparable
cartilage degradation in cartilage from male and female
mice spontaneously and after inﬂammatory cytokine (IL-
1a) stimulation ex vivo. Sex hormones have been demon-
strated to regulate different aspects of chondrocyte physiol-
ogy, including proliferation, differentiation, and extracellular
matrix synthesis13,18,33. Although estrogen receptors are
expressed similarly in male and female chondrocyte-
s19e21,34e36, E2 did not signiﬁcantly alter PG release from
cartilage of either sex in our culture system. This implies
that cartilage from males and females is equally susceptible
to degradation and factors extrinsic to cartilage may contrib-
ute to the differences observed in vivo. We did not compare
DHT or E2 responses in cartilage from sexually immature,
vs mature mice, since the PG release in this IL-1 stimulated
model rapidly declines with age (personal observations and
Chris Little, personal communication). It is possible that dif-
ferential effects following DHT or E2 stimulation may be ob-
served in cartilage from mature animals.
Our in vivo results with OVX mice were in agreement with
published OVX rat studies37,38 that demonstrated a protec-
tive role of female hormones on OA, and are consistent with
the observation that postmenopausal women are more
likely to develop OA with greater severity4e6. In vivo supple-
mentation of E2 to ORX males failed to demonstrate dis-
ease modiﬁcation and may be related to a failure of male
chondrocytes to respond to physiological levels of E218,19.
It is possible that the beneﬁcial effects of estrogen may
be more apparent in OVX females, but were not examined
in this study.
Unlike estrogen, a correlation between testosterone and
OA has not been established. In cartilage explant assays,
the effect of DHT on cartilage degradation was not apparent
following 3 days of IL-1a stimulation. Nevertheless, Raz et
al.13 have shown that chondrocytes exhibit sex-speciﬁc
and cell maturation dependent responses to DHT using thy-
midine incorporation and alkaline phosphatase activity as-
says. Despite the lack of efﬁcacy of DHT on cartilage in
the ex vivo study, ORX mice have repeatedly demonstrated
less severe OA and supplementing DHT reversed this phe-
nomenon completely. It is possible that the OA scores of
ORX males would be even closer to OVX females if ORX
or OVX were done earlier than 6 weeks of age. These re-
sults support the fact that testosterone may exacerbate
the susceptibility of male mice to OA.
Collectively, our data focus attention on the role of sex
hormones in the pathophysiology of OA. The effects of
sex hormones were only apparent in vivo suggesting that
sex hormones may have effects on OA beyond direct ef-
fects on chondrocytes. It is possible that estrogen could
have regulatory effects on immune cells that may directly
or indirectly contribute to the lower OA scores in intact fe-
males than OVX females39e42. Increased body weight is
a known risk factor for OA and OVX females weighed
8e11% more than the control females and they developed
44% more OA. ORX males weighed 6e8% less than the
control males and they had 47% less severe OA. However,
there was a lack of correlation between individual body
weights and severity of OA (data not shown) in the placebo
and DHT treated groups suggesting that body weight is not
the predominant factor for OA in this model. It is also possi-
ble that sex hormones can induce behavior and activity
changes that can ultimately inﬂuence the progression of
699Osteoarthritis and Cartilage Vol. 15, No. 6Fig. 6. Safranin-O histology showing severe loss of PG, ﬁbrillation and erosion of the medial tibia plateau cartilage of intact male mice (A). PG
loss and minor ﬁbrillation was observed in ORX males treated with either placebo (B) or E2 (C). Severe ﬁbrillation and erosion were observed
in ORX males treated with DHT at 8 weeks post-operatively (D). 10 magniﬁcation.OA as demonstrated in the guinea pig studies by Brismar
et al.43. Indeed, we found females are in general less active
than male mice (data not shown and A. Salvarrey-Strati,
personal communication). Understanding the mechanism
through which sex hormones regulate cartilage degradation
may assist the development of therapeutics aimed at target-
ing pathologic pathways in OA.
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